Tectonic Therapeutic IncNASDAQ:TECX
- LAST PRICE30.6000
- TODAY'S CHANGE (%)2.0200 (7.0679%)
- Bid / Lots28.6400/ 1
- Ask / Lots32.4200/ 1
- Open / Previous Close30.0200 / 28.5800
- Day Range
- 52 Week Range
- Volume236,006
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TECX |
|---|---|---|
| 09:32 ET | 2099 | 29.75 |
| 09:34 ET | 1801 | 29.65 |
| 09:36 ET | 700 | 30 |
| 09:38 ET | 200 | 30.2423 |
| 09:39 ET | 959 | 30.4899 |
| 09:41 ET | 4897 | 30.42 |
| 09:43 ET | 4400 | 30.07 |
| 09:45 ET | 5299 | 30.02 |
| 09:48 ET | 1600 | 30.02 |
| 09:50 ET | 600 | 30.2 |
| 09:52 ET | 300 | 30.22 |
| 09:54 ET | 1100 | 30.1 |
| 09:56 ET | 666 | 30 |
| 09:57 ET | 3500 | 30 |
| 09:59 ET | 950 | 29.75 |
| 10:01 ET | 100 | 29.83 |
| 10:03 ET | 200 | 29.8649 |
| 10:06 ET | 1495 | 30.115 |
| 10:08 ET | 4294 | 30.14 |
| 10:10 ET | 300 | 30.3236 |
| 10:12 ET | 10200 | 30.25 |
| 10:14 ET | 3382 | 30.11 |
| 10:15 ET | 1570 | 30.24 |
| 10:19 ET | 100 | 30.24 |
| 10:21 ET | 500 | 30.62 |
| 10:26 ET | 700 | 30.57 |
| 10:28 ET | 700 | 30.6 |
| 10:30 ET | 600 | 30.68 |
| 10:32 ET | 3614 | 30.74 |
| 10:33 ET | 675 | 30.91 |
| 10:35 ET | 830 | 30.99 |
| 10:37 ET | 200 | 31.125 |
| 10:39 ET | 297 | 31.1384 |
| 10:42 ET | 197 | 31.15 |
| 10:44 ET | 3529 | 31.115 |
| 10:46 ET | 174 | 31.0536 |
| 10:48 ET | 300 | 31.08 |
| 10:50 ET | 2588 | 30.96 |
| 10:51 ET | 226 | 31.11 |
| 10:53 ET | 200 | 31.055 |
| 10:55 ET | 1748 | 31.3 |
| 11:00 ET | 3903 | 31.33 |
| 11:02 ET | 5910 | 30.68 |
| 11:04 ET | 6932 | 30.93 |
| 11:06 ET | 500 | 30.99 |
| 11:08 ET | 4564 | 30.93 |
| 11:09 ET | 1500 | 31.1401 |
| 11:15 ET | 100 | 31.15 |
| 11:18 ET | 1300 | 30.98 |
| 11:20 ET | 300 | 30.88 |
| 11:26 ET | 100 | 30.76 |
| 11:27 ET | 109 | 30.9768 |
| 11:29 ET | 100 | 30.765 |
| 11:31 ET | 2970 | 31.22 |
| 11:33 ET | 940 | 30.905 |
| 11:36 ET | 200 | 30.819453 |
| 11:38 ET | 1182 | 31.1 |
| 11:42 ET | 100 | 31.0479 |
| 11:44 ET | 3200 | 31.15 |
| 11:45 ET | 760 | 30.7401 |
| 11:47 ET | 816 | 30.7943 |
| 11:51 ET | 400 | 31 |
| 11:58 ET | 216 | 30.81 |
| 12:02 ET | 160 | 30.73 |
| 12:03 ET | 100 | 30.725 |
| 12:05 ET | 135 | 30.8407 |
| 12:09 ET | 1065 | 30.39 |
| 12:14 ET | 300 | 30.29 |
| 12:16 ET | 100 | 30.39 |
| 12:20 ET | 1729 | 30.055 |
| 12:32 ET | 768 | 30.12 |
| 12:34 ET | 545 | 30.09 |
| 12:36 ET | 100 | 30.09 |
| 12:45 ET | 200 | 30.075 |
| 12:48 ET | 200 | 29.95 |
| 12:52 ET | 200 | 30 |
| 01:03 ET | 601 | 29.99 |
| 01:10 ET | 100 | 30.04 |
| 01:14 ET | 640 | 30.12 |
| 01:15 ET | 100 | 30.095 |
| 01:17 ET | 100 | 30.095 |
| 01:24 ET | 166 | 30.095 |
| 01:28 ET | 600 | 30.21 |
| 02:04 ET | 100 | 30.23 |
| 02:06 ET | 100 | 30.5 |
| 02:09 ET | 11353 | 30.6 |
| 02:40 ET | 100 | 30.6 |
| 02:44 ET | 100 | 30.52 |
| 02:47 ET | 2021 | 30.53 |
| 02:49 ET | 387 | 30.3 |
| 02:54 ET | 100 | 30.49 |
| 02:56 ET | 2200 | 30.3 |
| 02:58 ET | 100 | 30.35 |
| 03:00 ET | 1711 | 30.73 |
| 03:02 ET | 3421 | 30.95 |
| 03:03 ET | 1000 | 31.18 |
| 03:05 ET | 300 | 30.96 |
| 03:07 ET | 1600 | 31.045 |
| 03:09 ET | 200 | 30.96 |
| 03:12 ET | 600 | 30.955 |
| 03:14 ET | 700 | 30.985 |
| 03:16 ET | 5220 | 30.79 |
| 03:18 ET | 700 | 30.67 |
| 03:20 ET | 500 | 30.51 |
| 03:21 ET | 2634 | 30.85 |
| 03:23 ET | 2988 | 30.16 |
| 03:25 ET | 3642 | 30.17 |
| 03:27 ET | 2900 | 29.95 |
| 03:32 ET | 800 | 30.06 |
| 03:34 ET | 1570 | 30.355 |
| 03:36 ET | 500 | 30.355 |
| 03:38 ET | 1300 | 30.56 |
| 03:39 ET | 900 | 30.71 |
| 03:41 ET | 900 | 30.83 |
| 03:43 ET | 400 | 30.755 |
| 03:45 ET | 1000 | 30.83 |
| 03:48 ET | 1779 | 30.88 |
| 03:50 ET | 1325 | 30.76 |
| 03:52 ET | 600 | 30.72 |
| 03:54 ET | 2600 | 30.64 |
| 03:56 ET | 4715 | 30.445 |
| 03:57 ET | 3942 | 30.78 |
| 03:59 ET | 15230 | 30.6 |
Sep 24, 2024
DJ Tectonic Therapeutic Up Nearly 11%, on Track for Highest Close Since February 2022 -- Data Talk, from 12:54PM ET on Tuesday Sep 24, 2024 by Dow Jones
12:54PM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 19, 2024
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45, from 4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tectonic Therapeutic Inc | 265.1M | -1.7x | --- |
Rezolute Inc | 269.8M | -3.7x | --- |
Acrivon Therapeutics Inc | 276.0M | -2.6x | --- |
Biomea Fusion Inc | 284.2M | -2.5x | --- |
Trevi Therapeutics Inc | 244.6M | -8.6x | --- |
Immutep Ltd | 346.0M | -9.1x | --- |
Company Information
Tectonic Therapeutic, Inc. is a biotechnology company. The Company is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its technology platform called GEODe (GPCRs Engineered for Optimal Discovery), the Company is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. The Company’s lead program, TX000045 (TX45), is an Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone relaxin. TX45 is being evaluated in Phase Ia/Ib clinical trials as a potential treatment for Group 2 Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (HFpEF). Its second program addresses Hereditary Hemorrhagic Telangiectasia (HHT).
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 210WATERTOWN, MA, United States 02472
- Phone
- 339-666-3320
- Fax
- 302-655-5049
Executives
- President, Chief Executive Officer, Director
- Alise Reicin
- Chief Financial Officer
- Daniel Lochner
- Chief Scientific Officer
- Peter Mcnamara
- Chief Medical Officer
- Marcella Ruddy
- Chief Business Officer
- Marc Schwabish
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $265.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 14.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.20 |
EPS | $-18.52 |
Book Value | $25.46 |
P/E Ratio | -1.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
